Significant synovial pathology in a meniscectomy model of osteoarthritis: modification by intra-articular hyaluronan therapy.
about
A hexadecylamide derivative of hyaluronan (HYMOVIS®) has superior beneficial effects on human osteoarthritic chondrocytes and synoviocytes than unmodified hyaluronanThe mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic reviewUnravelling osteoarthritis-related synovial fibrosis: a step closer to solving joint stiffnessNitric oxide-driven hypoxia initiates synovial angiogenesis, hyperplasia and inflammatory lesions in miceContralateral cruciate survival in dogs with unilateral non-contact cranial cruciate ligament rupture.Differences among Branded Hyaluronic Acids in Italy, Part 1: Data from In Vitro and Animal Studies and Instructions for UseMeat consumption and risk of primary hip and knee joint replacement due to osteoarthritis: a prospective cohort study.Managing joint pain in osteoarthritis: safety and efficacy of hylan G-F 20Investigating triazine-based modification of hyaluronan using statistical designs.Weekly injections of Hylan G-F 20 delay cartilage degeneration in partial meniscectomized rat kneesInflammation in joint injury and post-traumatic osteoarthritisEfficacy Evaluation of a New Hyaluronan Derivative HYADD(®) 4-G to Maintain Cartilage Integrity in a Rabbit Model of Osteoarthritis.Non-terminal animal model of post-traumatic osteoarthritis induced by acute joint injury.Immunoselected STRO-3+ mesenchymal precursor cells reduce inflammation and improve clinical outcomes in a large animal model of monoarthritisIL-1ß and IL-8 are scavenged by the hexadecylamide derivative of hyaluronic acid: a new mechanism.Hyaluronic acid in the management of osteoarthritis: injection therapies innovations.Hyaluronan modulates accumulation of hypoxia-inducible factor-1 alpha, inducible nitric oxide synthase, and matrix metalloproteinase-3 in the synovium of rat adjuvant-induced arthritis modelAge-independent effects of hyaluronan amide derivative and growth hormone on human osteoarthritic chondrocytes.The nonlinear viscoelasticity of hyaluronic acid and its role in joint lubrication.Hyaluronan injection in murine osteoarthritis prevents TGFbeta 1-induced synovial neovascularization and fibrosis and maintains articular cartilage integrity by a CD44-dependent mechanism.Differential effect of molecular mass hyaluronan on lipopolysaccharide-induced damage in chondrocytes.Mechanosensitive hyaluronan secretion: stimulus-response curves and role of transcription-translation-translocation in rabbit joints.Protective effects of polydeoxyribonucleotides on cartilage degradation in experimental cultures.Single intra-articular dexamethasone injection immediately post-surgery in a rabbit model mitigates early inflammatory responses and post-traumatic osteoarthritis-like alterations.Longitudinal evaluation of effects of intra-articular mesenchymal stromal cell administration for the treatment of osteoarthritis in an ovine model.The role of protein content on the steady and oscillatory shear rheology of model synovial fluids.An Effective Translation: The Development of Hyaluronan-Based Medical Products From the Physicochemical, and Preclinical Aspects.
P2860
Q21245660-6356E41B-CD37-4AD5-A448-FE7D236CB33AQ26778884-40CA2347-AA53-47E9-ABE1-E0B4EC30FC32Q26801739-62EC8559-E510-43D3-9BBA-E22FB11F59B9Q28482073-361C1A69-3797-4C7D-968F-D4A7A1F22701Q31036913-B4A2E1D5-3781-464C-BB43-2FD60FBD12CBQ31105246-92919F7B-D109-4E06-A043-06C83A14CDAFQ33793650-2B05D445-46AA-4997-A1CF-ECB0CB9819F9Q34418260-2E070285-305F-462C-B827-2AB563347926Q35740842-DEA00505-6222-4C18-B49E-C1750327773AQ36000348-CAFB408A-A196-4751-96FD-D391E185DC50Q36242292-19DA84F9-F5A0-4DF4-8103-09E272141311Q36641181-C9294EB0-ACF0-4D5A-A77B-C7785F6FC4F6Q36759459-D5DA0217-7D72-4A62-B281-6A444D57DC64Q37630946-81DAF21B-701E-41AA-9F18-76023DFD4A66Q38908705-CDF39EDD-90C9-4C2F-9F54-21D44B14319CQ39030191-1EEAA23F-4C1E-498B-99FB-B92E7E92C046Q39185846-EA52949E-A0DC-4EF3-AC4F-3FF5D06B6D6EQ40834670-2745C8FF-8B39-467D-B4E9-4C38DF77C9DEQ41428897-FF8BF727-C67D-43CF-8551-711DB2D7CD41Q42135818-671FB5C9-A11B-449D-A7A5-C9C887024B02Q43285345-56369E40-AB41-4987-88D2-12A70168C831Q46166076-10910347-8A44-4A6B-865F-4F833A21B372Q50241017-11B160BD-F3BB-4F73-974A-489F0A8EBC9EQ53192556-E3DCC338-0182-48BA-824F-74CDAE5F3F6FQ53639725-46FC6DC9-42D9-418C-8079-F9BF25F5A014Q54439973-70E43199-2521-4E16-8DDA-369354C5756CQ55429009-1396A31E-EF62-4842-9A7D-1D6B87C58A98
P2860
Significant synovial pathology in a meniscectomy model of osteoarthritis: modification by intra-articular hyaluronan therapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Significant synovial pathology ...... -articular hyaluronan therapy.
@ast
Significant synovial pathology ...... -articular hyaluronan therapy.
@en
type
label
Significant synovial pathology ...... -articular hyaluronan therapy.
@ast
Significant synovial pathology ...... -articular hyaluronan therapy.
@en
prefLabel
Significant synovial pathology ...... -articular hyaluronan therapy.
@ast
Significant synovial pathology ...... -articular hyaluronan therapy.
@en
P2093
P2860
P356
P1433
P1476
Significant synovial pathology ...... -articular hyaluronan therapy.
@en
P2093
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEN219
P577
2008-06-19T00:00:00Z